Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A complex interaction between antitubercular treatment and acenocoumarol.

× No keyword cloud information.

12 in total

1. [Prolonged diminished effect of coumarin derivatives after use of rifampicin].

Authors: A M Harmsze; V H M Deneer; E H Wiltink
Journal: Ned Tijdschr Geneeskd Date: 2007-09-01

2. Delayed de-induction of CYP2C9 compared to CYP3A after discontinuation of rifampicin: Report of two cases .

Authors: Soichi Shibata; Harumi Takahashi; Akiyasu Baba; Kei Takeshita; Koichiro Atsuda; Hajime Matsubara; Hirotoshi Echizen
Journal: Int J Clin Pharmacol Ther Date: 2017-05 Impact factor: 1.366

3. Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities.

Authors: Yuki Nishimura; Norimitsu Kurata; Eriko Sakurai; Hajime Yasuhara
Journal: J Pharmacol Sci Date: 2004-11-05 Impact factor: 3.337

4. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes.

Authors: H H Thijssen; J P Flinois; P H Beaune
Journal: Drug Metab Dispos Date: 2000-11 Impact factor: 3.922

5. [Rimactan (rifampicin) and anticoagulant therapy].

Authors: F Michot; M Bürgi; J Büttner
Journal: Schweiz Med Wochenschr Date: 1970-03-28

Review 6. Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions.

Authors: Jiansong Yang; Mingxiang Liao; Magang Shou; Masoud Jamei; Karen Rowland Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal: Curr Drug Metab Date: 2008-06 Impact factor: 3.731

A complex interaction between antitubercular treatment and acenocoumarol.

1. [Prolonged diminished effect of coumarin derivatives after use of rifampicin].

2. Delayed de-induction of CYP2C9 compared to CYP3A after discontinuation of rifampicin: Report of two cases .

3. Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities.

4. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes.

5. [Rimactan (rifampicin) and anticoagulant therapy].

Review 6. Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions.

7. Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor.

8. Inhibition of cytochrome P450 by ethambutol in human liver microsomes.

9. Influence of rifampicin and isoniazid on the kinetics of phenytoin.

10. Effect of anti-tuberculosis therapy on polymorphic drug metabolizing enzyme CYP2C9 using phenytoin as a probe drug.